News
HIMS showcases outstanding financial strength. With just $63 million in debt against a market value of $13 billion, the ...
9h
Asianet Newsable on MSNHims & Hers Faces Retail Skepticism After Layoffs, FDA Ban on Compounded WegovyRetail investor sentiment around Hims & Hers Health remained negative over the weekend after the telehealth firm confirmed it ...
By Amina Niasse NEW YORK (Reuters) -Telehealth platform Hims & Hers said on Friday it will cut 68 employees, or about 4% of ...
Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...
Hims & Hers Health, Inc. navigates strong growth and partnerships despite rising competitive risks. Click here to read an ...
To sustain momentum, Hims recently announced a deal with Novo Nordisk A/S (NYSE: NVO) to distribute branded Wegovy at ...
Just 14 stocks with market caps above $1 billion have doubled so far this year. They probably aren't the winners you would ...
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
Hims to cut 4% of workforce amid ban on weight ... cancer risks Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related cancers ...
It's plainly apparent that Novo Nordisk has had May 22 circled its calendar since February, when the FDA began the countdown ...
Telemedicine company Hims & Hers has hired Farshad Shadloo to lead communications. As VP of communications, Shadloo reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results